Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.
D000818:Animals; D001380:Azauridine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D006711:Homocystine / Q000097:blood*; D008297:Male; D011732:Pyridoxal Phosphate / Q000097:blood*; D011736:Pyridoxine / Q000494:pharmacology*; D011817:Rabbits; D013997:Time Factors
D006711:Homocystine; D011732:Pyridoxal Phosphate; D001380:Azauridine; C100231:azaribine; D011736:Pyridoxine